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OBJECTIVES The goal of this study was to investigate the relation between serum cholesterol, arterial
stiffness and central blood pressure.
BACKGROUND Arterial stiffness and pulse pressure are important determinants of cardiovascular risk.
However, the effect of hypercholesterolemia on arterial stiffness is controversial, and central
pulse pressure has not been previously investigated.
METHODS Pressure waveforms were recorded from the radial artery in 68 subjects with hypercholester-
olemia and 68 controls, and corresponding central waveforms were generated using pulse
wave analysis. Central pressure, augmentation index (AIx) (a measure of systemic stiffness)
and aortic pulse wave velocity were determined.
RESULTS There was no significant difference in peripheral blood pressure between the two groups, but
central pulse pressure was significantly higher in the group with hypercholesterolemia (37 
11 mm Hg vs. 33  10 mm Hg [means  SD]; p  0.028). Augmentation index was also
significantly higher in the patients with hypercholesterolemia group (24.8  11.3% vs. 15.6 
12.1%; p  0.001), as was the estimated aortic pulse wave velocity. In a multiple regression
model, age, short stature, peripheral mean arterial pressure, smoking and low-density
lipoprotein cholesterol correlated positively with AIx, and there was an inverse correlation
with heart rate and male gender.
CONCLUSIONS Patients with hypercholesterolemia have a higher central pulse pressure and stiffer blood
vessels than matched controls, despite similar peripheral blood pressures. These hemody-
namic changes may contribute to the increased risk of cardiovascular disease associated with
hypercholesterolemia, and assessment may improve risk stratification. (J Am Coll Cardiol
2002;39:1005–11) © 2002 by the American College of Cardiology Foundation
Arterial stiffening is an inevitable part of the aging process
in nearly all societies (1,2), and it is associated with a rise in
pulse pressure (3). The importance of pulse pressure as a
predictor of cardiovascular mortality has been demonstrated
by several recent population-based and interventional stud-
ies (4–7) and has focused attention on arterial stiffness as a
key determinant of cardiovascular risk. “Premature arterial
stiffening” occurs in association with several important
cardiovascular risk factors including hypertension, diabetes
mellitus and cigarette smoking (8), which are also associated
with endothelial dysfunction (9). Whether arterial stiffening
represents a marker of occult atheroma, or endothelial
dysfunction, or is more directly involved in the process of
atherosclerosis remains unclear (10).
Hypercholesterolemia is a major risk factor for cardiovas-
cular disease, and it is also associated with endothelial
dysfunction (11). However, there are conflicting data con-
cerning the relationship between hypercholesterolemia and
local arterial stiffness (12). Moreover, the effect of hypercho-
lesterolemia on systemic arterial stiffness has only been
investigated in one previous study (13), and central blood
pressures were not assessed. We hypothesized that hyper-
cholesterolemia would be associated with increased systemic
arterial stiffness and central pulse pressure, and the aim of
this study was to test this hypothesis in a group of otherwise
healthy individuals with hypercholesterolemia and matched
controls using the technique of pulse wave analysis (PWA).
We have previously demonstrated that PWA is a reproduc-
ible, noninvasive method for assessing central blood pres-
sure and augmentation index (AIx) (14)—a measure of the
contribution that wave reflection makes to the arterial
pressure waveform. The amplitude and timing of the
reflected wave ultimately depend on the stiffness of the small
(preresistance) vessels and large arteries and thus, AIx
provides a measure of systemic arterial stiffness.
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METHODS
Sixty-eight patients with hypercholesterolemia, defined as a
total serum cholesterol 6.5 mmol/l, were recruited from
the cardiovascular risk clinics at the Western General
Hospital in Edinburgh and the University Hospital of
Wales in Cardiff and from general practices local to both
hospitals. Concurrently, normocholesterolemic controls (to-
tal serum cholesterol 6.5 mmol/l) were recruited from the
same sources and community databases of volunteers held at
both hospitals and selected such that, as a group, their
distribution of age, gender and weight closely matched the
patient group. Approval for the study was obtained from the
respective Local Research Ethics Committees, and in-
formed consent was obtained from each participant. Pa-
tients with elevated blood pressure (brachial artery blood
pressure 160/100 mm Hg), treated hypertension, diabetes
mellitus (British Diabetic Association criteria) or a clinical
history of cardiovascular disease were excluded, as were
subjects receiving any medication. Cigarette smokers were
allowed to participate, having abstained for at least 4 h.
Blood pressure measurement. Systolic and diastolic blood
pressure were recorded in duplicate in the dominant arm
using a validated oscillometric technique (HEM-705CP,
Omron Corporation, Tokyo, Japan) (15). Peripheral mean
arterial pressure (PMAP) was calculated by integration of
the pressure waveform using the sphygmoCor version 6.1
software (AtCor Medical, Sydney, Australia).
Measurement of arterial stiffness and central blood pres-
sure. Pulse wave analysis was used to determine systemic
arterial stiffness (sphygmoCor version 6.1 software) as
previously described (14). A high-fidelity micromanometer
(SPC-301, Millar Instruments, Houston, Texas) was used
to obtain accurate recordings of the peripheral pressure
waveforms by flattening, but not occluding, the radial artery
of the dominant arm using gentle pressure (16). Data were
collected directly into a microcomputer and, after 20 se-
quential waveforms had been acquired, an averaged periph-
eral waveform was generated. A corresponding averaged
central pressure waveform was then generated using a
validated transfer function (17–20), and, from this, augmen-
tation, AIx, ascending aortic pressure and heart rate were
then determined using the integral software.
Augmentation represents the difference between the sec-
ond and first systolic peaks of the central pressure waveform,
and AIx is defined as augmentation expressed as a percent-
age of the pulse pressure (Fig. 1) and is a measure of systemic
arterial stiffness. The tension time index (TTI), the area
under the systolic portion of the pressure waveform per
minute (the systolic pressure-time integral), an index of
systolic stress and the diastolic pressure-time integral
(DPTI) were also determined (21,22). The aortic pulse
wave velocity was estimated by calculating the time between
the foot of the pressure wave and the inflection point, which
provides a measure of the timing of the reflected wave, as
described previously (23,24).
Study protocol. After 5 min seated rest in a quiet room,
blood pressure was measured. Augmentation, AIx and
central arterial pressure were then determined using PWA.
All measurements were made in duplicate and mean values
used for analysis. Venous blood was then drawn from the
antecubital fossa for measurement of plasma glucose, total
serum cholesterol, low-density lipoprotein (LDL), high-
density lipoprotein (HDL) cholesterol and triglycerides.
Finally, height and weight were recorded and body mass
index calculated.
Data analysis. Data were analyzed using unpaired, two-
tailed Student t tests and multiple regression analysis (SPSS
software package, version 10, SPSS Inc., Chicago, Illinois).
Unless stated otherwise, all results are presented as means
SD. Significance was defined as p  0.05.
RESULTS
Sixty-eight subjects with hypercholesterolemia, aged 51 
10 years (range: men 29 to 77 years, women 39 to 73 years),
and 68 control subjects, aged 51  10 years (range: men 25
to 75 years, women 32 to 74 years), were entered into the
study. There was no significant difference in age, gender,
height, weight or the number of smokers between the two
groups, but serum LDL cholesterol and triglycerides were
significantly higher in the hypercholesterolemic group (Ta-
ble 1).
A summary of the peripheral and central hemodynamics
is presented in Table 2 and Figure 2. Peripheral blood
pressure did not differ between the groups, although the
Abbreviations and Acronyms
AIx  augmentation index
DPTI  diastolic pressure time integral
FH  familial hypercholesterolemia
HDL  high-density lipoprotein
LDL  low-density lipoprotein
PMAP  peripheral mean arterial pressure
PWA  pulse wave analysis
TTI  tension time index
Figure 1. Representative ascending aortic waveforms from a young and
older subject (Murgo type “C” and “A” waves, respectively); note the
prominence of the second systolic peak (*) in the older individual.
Augmentation index is defined as the difference between the second and
first systolic peaks (P) expressed as a percentage of the pulse pressure
(PP).
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control group had a higher resting heart rate. Augmenta-
tion, AIx and central pulse pressure were significantly higher
in the subjects with hypercholesterolemia compared with
controls, and there was a trend towards a higher central
systolic pressure in the hypercholesterolemic group. The
difference in AIx between the two groups persisted after
correction for height and heart rate (18.4  7.6 vs. 23.1 
6.1, p  0.004). The TTI (2,296  380 vs. 2,320  438,
p 0.7) and DPTI (3,743 559 vs. 3,613 455, p 0.2)
were similar in both groups. There were fewer Murgo type
“A” waves (23) in the control subjects compared with the
subjects with hypercholesterolemia (40 vs. 57) and more
type “B” (20 vs. 10) and “C” (8 vs. 1) waves (p  0.003 for
trend; chi-square).
Data from all 136 subjects were used to construct two
multiple regression models with AIx and estimated aortic
pulse wave velocity as the dependent variables. Age, gender,
height, heart rate, PMAP, smoking history, LDL choles-
terol, HDL cholesterol and triglycerides were entered into
the models as known or likely determinants of arterial
stiffness. Age, short stature, PMAP, smoking and LDL
cholesterol, but not HDL cholesterol or triglycerides, cor-
related positively with AIx, and there was an inverse
correlation with heart rate and male gender (Table 3). The
model explained 62% of the variability in AIx observed in
the study (p  0.001). Substituting augmentation for the
dependent variable did not make a significant difference to
the correlations in the regression model, neither did the
addition of plasma glucose or changing the method of analysis
to stepwise regression. Estimated aortic pulse wave velocity
correlated positively with LDL cholesterol and smoking and
inversely with male gender and height (Table 4).
DISCUSSION
A number of studies have investigated the relationship
between hypercholesterolemia and arterial stiffness. In ani-
mals, hypercholesterolemia, induced by a cholesterol-rich
diet, results in an initial reduction in arterial stiffness,
followed by a progressive increase over time (25,26), which
can be reversed by lowering serum cholesterol (26,27). In
humans, a variety of techniques have been used to assess
vascular stiffness in vivo, with conflicting results. Lehmann
et al. (28) demonstrated increased distensibility, as deter-
mined by aortic pulse wave velocity, in a group of young
patients with heterozygous familial hypercholesterolemia
(FH) but, in contrast, reported reduced aortic distensibility
in adults with FH (12). Others have also observed reduced
radial artery compliance in adults with FH compared with
controls (29). However, Toikka et al. (30) reported no
difference in aortic or carotid compliance between asymp-
tomatic adults with FH and controls.
In subjects without FH, most (30–33), but not all (13),
studies have reported an inverse relationship between either
LDL cholesterol or total cholesterol and aortic compliance.
Differences in the vessels studied, patient selection and
small sample sizes are likely to account for these discrepant
findings. Indeed, Kool et al. (34) reported reduced arterial
distensibility in some, but not all, arteries in individuals with
hypercholesterolemia. However, all of these studies, with
one exception (13), have focused on the stiffness of easily
accessible arterial beds or even one small segment of an
artery, and not on systemic arterial stiffness, which has a
major influence on the interaction between the arterial tree
and the left ventricle (35). Indeed, the shape of the central
pressure waveform partly determines left ventricular work-
load (35). Therefore, assessing systemic stiffness may be of
more clinical importance than measuring compliance within
an isolated vascular bed. Moreover, the effect of hypercho-
lesterolemia on central blood pressure has not been previ-
ously investigated.
In this study we recorded peripheral pressure waveforms
using applanation tonometry and generated corresponding
Table 2. Hemodynamics
HR
(min1)
PSBP
(mm Hg)
PDBP
(mm Hg)
PPP
(mm Hg)
Alx
(%)
Aug
(mm Hg)
TR
(ms)
CSBP
(mm Hg)
CDBP
(mm Hg)
CPP
(mm Hg)
PPP:CPP
(Ratio)
HC 70  9 132  15 84  11 49  12 24.8  11.3 9.9  5.9 140  13 122  17 85  12 37  11 1.34  0.25
Controls 74  12 131  15 84  11 47  13 15.6  12.1 5.8  5.3 145  11 118  17 85  11 33  10 1.45  0.24
Significance
(p Value)
0.026 0.6 1.0 0.5  0.001  0.001 0.013 0.1 0.9 0.028 0.012
All values are expressed as means  SD.
AIx  augmentation index; Aug  systolic augmentation; CDBP  central diastolic blood pressure; CPP  central pulse pressure; CSBP  central systolic blood pressure;
HC  hypercholesterolemics; HR  heart rate; PDBP  peripheral diastolic blood pressure; PPP  peripheral pulse pressure; PSBP  peripheral systolic blood pressure.
Table 1. Subject Characteristics
Number
(n)
Men
(n)
Age
(yrs)
Height
(m)
Weight
(kg)
Smokers
(n)
Cholesterol
TG
(mmol/l)
Glucose
(mmol/l)
Total
(mmol/l)
LDL
(mmol/l)
HDL
(mmol/l)
Hypercholesterolemics 68 25 51  10 1.70  0.08 77.5  14.4 24 7.1  0.5 4.7  0.7† 1.3  0.4 2.2  1.4* 5.1  1.0
Controls 68 25 51  10 1.73  0.10 78.8  13.0 21 5.0  0.7 2.8  0.7 1.4  0.5 1.6  0.8 5.2  0.7
All values are expressed as means  SD. There were no significant differences between the groups for any parameter, unless stated. *p  0.05; †p  0.001 (unpaired Student
t test).
HDL  high-density lipoprotein; LDL  low-density lipoprotein; TG  triglycerides.
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central arterial pressure waveforms using PWA. The main
novel findings were an increased AIx and central pulse
pressure in individuals with hypercholesterolemia compared
with matched normocholesterolemic controls (Fig. 2). The
AIx is a measure of the contribution made by the reflected
pressure wave to the ascending aortic pressure waveform
(36) and, thus, provides a measure of systemic arterial
stiffness (37). Therefore, the present data demonstrate that
hypercholesterolemia is associated with increased systemic
arterial stiffness; this conclusion is supported by the higher
frequency of Murgo type “A” waves among the subjects with
hypercholesterolemia. Importantly, aortic pulse wave veloc-
ity, estimated from the timing of the reflected wave, was also
increased in the subjects with hypercholesterolemia, indi-
cating increased aortic stiffness and that the observed
changes in AIx were not solely due to differences in wave
reflection.
A number of factors, including gender, heart rate and
height are known to influence AIx, independently of
changes in stiffness (22,38). However, none of these vari-
ables, other than heart rate, differed significantly between
the two groups. Moreover, after correction for heart rate and
height, AIx remained significantly higher in the hypercho-
lesterolemic group. Furthermore, in the multiple regression
model, which included known confounding variables, LDL,
but not HDL, cholesterol was a significant independent
determinant of AIx (Table 3). The model accounted for
65% of the observed variability of AIx, which compares
favorably with other published multiple regression models
(22,32). In addition, we also confirmed the positive relation
of age, female gender, short stature, PMAP and low heart
rate with AIx (22) and here, for the first time, demonstrated
that chronic smoking is associated with an increased AIx
(Table 3). We and others have previously demonstrated that
individuals with diabetes mellitus (39) and insulin resistance
(40) have a higher AIx than matched controls and that
insulin per se can influence arterial stiffness (41). However,
there was no relation between AIx and serum glucose in this
present study. The most likely explanation for this is that we
actively excluded patients with diabetes mellitus and, there-
fore, only studied individuals within a rather narrow range
of serum glucose concentrations.
The multiple regression model investigating the determi-
nants of estimated aortic pulse wave velocity confirmed that
Table 3. Results of the Multiple Regression Analysis With Augmentation Index as the
Dependent Variable
Parameters Units
Regression
Coefficient SE Beta Significance
Gender male 8.98 2.13 0.34 0.001
Age years 0.45 0.08 0.38 0.001
Heart rate min1 0.40 0.07 0.33 0.001
PMAP mm Hg 0.198 0.061 0.20 0.001
LDL cholesterol mmol/l 2.18 0.71 0.20 0.003
Height m 20.89 10.67 0.16 0.043
Smoker 4.076 1.536 0.15 0.009
HDL cholesterol mmol/l 3.41 2.03 0.12 0.1
Triglycerides mmol/l 1.34 0.78 0.12 0.1
Multiple regression analysis using all 136 subjects. R2 value for the entire study group  0.651, p  0.001.
The regression coefficient provides the slope of the regression line relating each parameter to augmentation index, and the
coefficient beta provides a measure of the relative strength of the association independent of the units of measurement.
Parameters listed in descending value of beta.
HDL  high-density lipoprotein; LDL  low-density lipoprotein; PMAP  peripheral mean arterial pressure; SE 
standard error.
Figure 2. Box and whisker plots for augmentation index (AIx), augmentation and estimated aortic pulse wave velocity (TR) for the hypercholesterolemia
(HC) and control subjects. Solid horizontal lines  median values; error bars  95% confidence intervals; shaded area  interquartile range. n  163;
*p  0.01; **p  0.001.
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LDL cholesterol was independently associated with aortic
stiffening. Height was inversely related to estimated pulse
wave velocity, which is to be expected, as we did not correct
for path length but simply used the arrival of the reflected
wave as a measure of aortic pulse wave velocity. Therefore,
for a given pulse wave velocity, taller subjects with a longer
aortae will have a prolonged transit time.
Peripheral pulse pressure, a surrogate measure of arterial
stiffness and important predictor of cardiovascular mortality
(4,5,42), did not differ significantly between the two groups.
However, we have demonstrated, for the first time, in-
creased central pulse pressure in subjects with hypercholes-
terolemia compared with controls and a reduction in the
degree of pressure amplification. Systolic pressure varies
throughout the arterial tree due to wave reflection and
differences in vessel stiffness. Normally, there is an ampli-
fication of pulse pressure from the central to peripheral
arteries, but the degree of amplification depends on a
number of factors including heart rate (38) and posture (43).
Therefore, peripheral pulse pressure does not always predict
central pulse pressure, which is important because central,
not brachial artery, pressure best defines left ventricular
workload and, thus, left ventricular mass—an important and
independent predictor of cardiovascular mortality (44).
Moreover, carotid pulse pressure correlates more closely
with carotid intima-media thickness than brachial pulse
pressure (45) and predicts restenosis after angioplasty (46).
However, whether measurement of central pulse pressure
will improve risk stratification remains to be proven. Nev-
ertheless, we have demonstrated that simply assessing bra-
chial artery pressure does not reliably predict central hemo-
dynamics, which may explain the lack of correlation
between peripheral blood pressure and serum cholesterol in
a recent study (47).
Whether structural changes in the arterial wall alone are
responsible for the increase in arterial stiffness reported in
this and other studies is unclear. Although we did not
include subjects with a history of vascular disease or mani-
fest evidence of atheroma, we cannot exclude the possibility
of occult atheroma in the hypercholesterolemic group being
responsible for the observed arterial stiffening. However,
mounting evidence suggests that there is a degree of
functional regulation of stiffness by the vascular endothe-
lium (48,49). Hypercholesterolemia is strongly associated
with endothelial dysfunction and reduced nitric oxide bio-
availability (11,49), which may lead to a degree of functional
and, therefore, potentially reversible arterial stiffening. In-
deed, in animal models of hypercholesterolemia, cholesterol
lowering appears to reduce arterial stiffness (26,27). In
humans, HMG-CoA reductase (statin) therapy has also
been associated with a reduction in aortic pulse wave
velocity within six months (50), but not any improvement in
femoral, carotid or brachial artery distensibility within eight
weeks (34). Finally, although we assessed arterial stiffness
and central pressures noninvasively using PWA rather than
directly, the transfer function involved has been validated.
However, aortic pulse wave velocity was estimated from the
timing of the reflected pressure wave rather than measured
using a foot-to-foot methodology.
In summary, we have shown increased systemic arterial
and aortic stiffness and, for the first time, central pulse
pressure in asymptomatic patients with hypercholesterol-
emia. Stiffness was independently correlated with LDL but
not HDL cholesterol. Large-scale studies are now required
to investigate further the influence of hypercholesterolemia
on central arterial pressure and left ventricular load. Multi-
center studies investigating the effect of various therapeutic
interventions on arterial stiffness, including cholesterol-
lowering and folate supplementation in hypercholester-
olemic subjects (Study of the Effectiveness of Additional
Reduction in Cholesterol and Homocysteine [SEARCH]),
are currently ongoing (51), and these will serve not only to
provide data concerning the importance of systemic arterial
stiffness as a predictor of outcome but will also determine
the effects of therapeutic intervention. Mechanistic studies
are also required to investigate the relationship between
cholesterol, arterial stiffness and endothelial function and
may serve to elucidate the role of the endothelium in
regulation of arterial stiffness.
Table 4. Results of the Multiple Regression Analysis With Estimated Aortic Pulse Wave
Velocity (TR) as the Dependent Variable
Parameters Units
Regression
Coefficient SE Beta Significance
Gender male 8.80 2.51 0.38 0.001
LDL cholesterol mmol/l 1.63 0.84 0.17 0.046
PMAP mm Hg 0.15 0.08 0.17 0.06
Heart rate min1 0.16 0.08 0.17 0.06
Smoker 4.22 2.14 0.17 0.050
Age yrs 0.17 0.09 0.16 0.08
Height m 13.45 12.60 0.12 0.037
HDL cholesterol mmol/l 0.50 2.34 0.02 0.8
Triglycerides mmol/l 0.43 0.92 0.04 0.6
Multiple regression analysis using all 136 subjects. R2 value for the entire study group  0.364, p  0.001. Parameters listed in
descending value of beta.
HDL  high-density lipoprotein; LDL  low-density lipoprotein; PMAP  peripheral mean arterial pressure.
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